¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÇ÷°ü¿Ü°úÇÐȸ Á¦73Â÷ Ãá°èÇмú´ëȸ : 2021-04-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÇ÷°ü¿Ü°úÇÐȸ Á¦73Â÷ Ãá°èÇмú´ëȸ : 2021-04-16
±³À°ÀÏÀÚ : 2021-04-16
±³À°Àå¼Ò : BEXCO  
±³À°ÁÖÁ¦ : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ Á¦73Â÷ Ãá°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ
´ã´çÀÚ : ±èÇü±â
¿¬¶ôó : 02-1111-1111  
À̸ÞÀÏ : ksvs@chol.com      
±³À°Á¾·ù : ¿Ü°ú, ¿µ»óÀÇÇаúÀÇ»çÇÐ, ÇغÎÇÐ, ÀÇÇб³À°,      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 5ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í • Á¤È¸¿ø Àü¹®ÀÇ:50,000¿ø, ºñȸ¿ø Àü¹®ÀÇ:80,000¿ø, ÁØȸ¿ø, Àü°øÀÇ, °£È£»ç, ±â»ç, ±âŸ:¹«·á • Äڷγª¹ÙÀÌ·¯½º-19 È®»ê ¹æÁö ¹× Á¤È®ÇÑ Âü¼®ÀÚ Àοø ÆľÇÀ» À§ÇÏ¿© À̹ø Ãá°èÇмú´ëȸ´Â ÇöÀåµî·ÏÀ» ¹ÞÁö ¾Ê±â·Î ÃÖÁ¾ °áÁ¤µÇ¾ú½À´Ï´Ù. • ÇöÀå Âü¼®Àº ÁöÁ¤µÈ ¿¬ÀÚ, ÁÂÀå, ÆгÎ, ÃÊ·Ï Ã¤ÅÃÀÚ¸¸ °¡´ÉÇϸç, ÀÌ ¿Ü¿¡´Â ÇöÀå Âü¼®ÀÌ Àý´ë ºÒ°¡ÇÑ Á¡ ¾çÇØ ¹Ù¶ø´Ï´Ù. • °í¹®, ÀÚ¹®, 65¼¼ ÀÌ»ó Á¤È¸¿ø, ÇлýÀº ¹«·á µî·Ï (ÇлýÀº ´çÀÏ ÇлýÁõ È®ÀÎ) • ÇÐȸ ¿¬È¸ºñ¸¦ ³³ºÎÇÑ ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ Á¤È¸¿ø¿¡ ÇÑÇÏ¿© ȸ¿ø µî·Ïºñ°¡ Àû¿ëµË´Ï´Ù. • ¸ðµç Âü¼®ÀÚ Ã¼¿Â ÃøÁ¤ ¿¹Á¤ / ¸¶½ºÅ© ¹ÌÂø¿ëÀÚ ÃâÀÔ ºÒ°¡      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ13:00~14:00 Registration  () 
±âŸ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ14:00~14:05 Opening Address  Çã½Â(´ëÇÑÇ÷°ü¿Ü°úÇÐȸ ÀÌ»çÀå) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ14:05~14:20 (Recorded live case 1) Aortic surgery via retroperitoneal approach: how I do it  ¹Ú¾çÁø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ14:20~14:30 Techniques to avoid visceral/renal ischemia during suprarenal abdominal aortic aneurysm repair  ÇÑ¿µÁø(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ14:30~14:45 (Recorded live case 2) Distal tibial/peroneal bypass: technical tips  ±èÇü±â(°æºÏÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ14:45~14:55 Anastomotic techniques to improve patency in small caliber diseased vessels  È²Á¤±â(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ14:55~15:10 (Recorded live case 3) Carotid endarterectomy: shunt  ¾ç½Å¼®(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ15:10~15:20 Updates on recent trials for carotid artery stenosis treatment  ±èÇâ°æ(¿ï»êÀÇ´ë) 
Åä·Ð 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ15:20~15:30 Discussion  ¹Î½Â±â ¾È¹®»ó ȲȫÇÊ ÀÌÈ£±Õ ¾È»óÇö ³ë¿µ³²(¼­¿ïÀÇ´ë Ãæ³²ÀÇ´ë ÀüºÏÀÇ´ë Àü³²ÀÇ´ë ¼­¿ïÀÇ´ë °è¸íÀÇ´ë) 
È޽Ġ04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ15:30~15:50 Coffee break  () 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ15:50~16:05 (Recorded live case 4) EVAR with endoAnchors: when and how?  ÀÌ»ó¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ16:05~16:20 (Recorded live case 5) EVAR with IBD: indications and limitations  ±è»óµ¿(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ16:20~16:30 EVAR for challenging anatomies: how to improve my technique  À±¿ì¼º(°æºÏÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ16:30~16:45 (Recorded live case 6) Endovascular treatment of multilevel CTO: tips and tricks  ¹ÚÀÇÁØ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ16:45~16:55 DCB safety: updates of the recent SWEDEPAD trial  ±è¼­¹Î(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ16:55~17:10 (Recorded live case 7) How to use different percutaneous closure devices  Á¶ÁøÇö(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ17:10~17:20 Access related complications: overview and how to avoid them  Á¤ÇõÀç(ºÎ»êÀÇ´ë) 
Åä·Ð 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ17:20~17:30 Discussion  ÀÌ»ó¼ö Á¶ÁøÇö ¹ÚÇü¼· ¿ÀÇàÁø À¯¿µ¼± ÀÌÀçÈÆ(ºÎ»êÀÇ´ë °æÈñÀÇ´ë ¼­¿ïÀÇ´ë ÀÎÁ¦ÀÇ´ë Á¶¼±ÀÇ´ë ´ë±¸°¡Å縯ÀÇ´ë) 
±âŸ 04¿ù 16ÀÏ º¤½ºÄÚ Á¦1Àü½ÃÀå 2Ãþ ȸÀǽǠ17:30~17:40 Closing remarks  Çã½Â(´ëÇÑÇ÷°ü¿Ü°úÇÐȸ ÀÌ»çÀå) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ Á¦73Â÷ Ãá°èÇмú´ëȸ : 2021-04-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2021³â ´ëÇѱٰñ°Ý¿µ»óÀÇÇÐȸ ¿Â¶óÀÎ Á¤±âÇмú´ëȸ : 2021-04-16
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ) ¾È°ú ±Ý¿äÁý´ãȸ : 2021-04-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
450 ºÎ»ê µ¿¾Æ´ëÇб³ÀÇ·á¿ø ÀÓ»ó ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ ÁßÀçÄ¡·á½Ã¼úÀÇ ÇöÀç¿Í ¹Ì·¡ : 2018-08-25 0 528 2018-08-22
449 °æ±â 2018³â ´ëÇѱٰ¨¼ÒÁõÇÐȸ Á¦6Â÷ Çмú´ëȸ : 2018-08-25 0 486 2018-08-22
448 ¼­¿ï Çѱ¹ÀÇÇй°¸®ÇÐȸ 2018 ¿©¸§ ÀÇÇй°¸®½ÉÈ­±³À° 1 : 2018-08-24 0 408 2018-08-22
447 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ : 2018-09-21 0 662 2018-08-15
446 °æ±â ÇѸ²´ë ÆòÃ̼º½Éº´¿ø ´ëÇÑ°£ÇÐȸ Extrahepatic manifestation of HBV, HBV integration: global pattern and biological function : 2018-09-20 0 4,820 2018-08-15
445 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦17Â÷ ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¤±âÁý´ãȸ : 2018-09-19 0 960 2018-08-15
444 ¼­¿ï ´ëÇÑ°³¿ø¿µ»óÀÇÇаúÀÇ»çȸ Á¦20Â÷ °ËÁø Çмú´ëȸ ¹× Á¦15Â÷ ÃÊÀ½ÆÄ¿¬¼ö±³À° : 2018-09-16 0 1,152 2018-08-15
443 ¼­¿ï °Ç±¹´ëº´¿ø Á¦5Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ °üÀýÃÊÀ½ÆÄ ¿öÅ©¼ó : 2018-09-16 0 732 2018-08-15
442 ¼­¿ï ´ëÇÑÄ¡¸ÅÇÐȸ 2018 Ãß°è º¸¼ö±³À° : 2018-09-16 0 832 2018-08-15
441 ¿ï»ê Á¦5ȸ ¿ï»ê´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú ¿¬¼ö°­Á : 2018-09-15 0 1,362 2018-08-15
440 Á¦ÁÖ ´ëÇÑÄ¡·áÃÊÀ½ÆÄÇÐȸ Á¦4ȸ Á¤±âÇмú´ëȸ : 2018-09-15 0 1,440 2018-08-15
439 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 4ÀÏÂ÷ : 2018-09-15 0 1,488 2018-08-15
438 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Çѱ¹½Å°æ¾È°úÇÐȸ Á¤±â½ÉÆ÷Áö¾ö : 2018-09-15 0 799 2018-08-15
437 ¼­¿ï °Ç±¹´ëÇб³º´¿ø ´ëÇѳú½Å°æÀçÈ°ÇÐȸ 2018³âµµ ¿öÅ©¼ó : 2018-09-15 0 623 2018-08-15
436 ¼­¿ï °Ç±¹´ëÇб³º´¿ø ´ëÇѳú½Å°æÀçÈ°ÇÐȸ 2018³âµµ Ã߰迬¼ö°­Á : 2018-09-15 0 349 2018-08-15
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷